Table 1.
Clinical characteristics and comparison of the Ofloxacin & Rifampicin and Doxycycline & Rifampicin group
| Clinical findings | Doxycycline & Rifampicin group (n = 14) | Ofloxacin & Rifampicin group (n = 15) |
| Age (years) (median-range) | 29 (24–61) | 35 (18–60) |
| Male/Female | 11/3 | 13/2 |
| Hepatomegaly (n) | 7 | 9 |
| Fever (n) | 13 | 15 |
| Arthralgia (n) | 13 | 13 |
| Headache (n) | 10 | 11 |
| Sweating (n) | 12 | 10 |
| Splenomegaly (n) | 7 | 7 |
| Diagnosis with culture (n) | 4 | 3 |
| Diagnosis with agglutination (n) | 12 | 13 |
| Adverse effects | ||
| - Diarrhea (n) | 1 | 2 |
| - Nausea and vomiting (n) | 3 | 1 |
| Complication (n) | 2 Sacroileitis | 1 Sacroileitis ** 1 Orchitis |
| Relapse (n) | 2 | 2 ** |
| Duration of fever after starting treatment (mean ± SD) (hours) | 106 ± 26 | 74 ± 30 * |
*p < 0.05. ** p > 0.05